T. Plunkett

发表

Principles of Immunology

D. Miles, I. Correa, T. Plunkett, 2002 .

Quality of life and the treatment of advanced lung cancer.

P. Harper, T. Plunkett, K. Chrystal, 2003, Clinical lung cancer.

The biology and management of bone metastases.

R. Rubens, T. Plunkett, 1999, Critical reviews in oncology/hematology.

Bisphosphonate therapy for patients with breast carcinoma

R. Rubens, T. Plunkett, Robert D. Rubens, 2003, Cancer.

Risk of complications from bone metastases in breast cancer. implications for management.

Philip Smith, R. Rubens, P. Smith, 2000, European journal of cancer.

Responses of human T cells to peptides flanking the tandem repeat and overlapping the signal sequence of MUC1

J. Burchell, J. Coleman, I. Correa, 2005, International journal of cancer.

Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T‐cell migration

J. Taylor‐Papadimitriou, J. Burchell, A. Vlad, 2003, Immunology.

Breast Cancer and the Immune System: Opportunities and Pitfalls

J. Taylor‐Papadimitriou, I. Correa, T. Plunkett, 2001, Journal of Mammary Gland Biology and Neoplasia.

Immunotherapy for Breast Cancer: Promises, Promises …

J. Taylor‐Papadimitriou, D. Miles, T. Plunkett, 2000 .

Update on HER-2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition

I. Correa, T. Plunkett, 2001, Breast Cancer Research.

Protection against MUC1 expressing mouse tumours by intra‐muscular injection of MUC1 cDNA requires functional CD8+ and CD4+ T cells but does not require the MUC1 tandem repeat domain

J. Taylor‐Papadimitriou, D. Miles, J. Burchell, 2004, International journal of cancer.

Clinical case Metastatic eccrine porocarcinoma: Response to docetaxel (Taxotere) chemotherapy

D. Miles, R. Rubens, A. Hanby, 2005 .

Coexistence of acanthosis nigricans and the sign of Leser-Trélat in a patient with gastric adenocarcinoma: a case report and literature review.

P. Harper, S. Munn, P. Harper, 2000, Journal of the American Academy of Dermatology.

Management of Merkel cell carcinoma

P. Harper, T. Plunkett, M. Leslie, 2001, Expert review of anticancer therapy.

MUC1 and the Immunobiology of Cancer

J. Taylor‐Papadimitriou, D. Miles, J. Burchell, 2002, Journal of mammary gland biology and neoplasia.

Immunotherapy and breast cancer.

D. Miles, T. Plunkett, 1998, Cancer treatment reviews.

Cellular immunotherapy for cancer: current concepts and clinical perspectives Monitoring immune responses and clinical trials: part II.

H. Pandha, J. Spicer, J. Spicer, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

Immunotherapy: the last 25 years.

D. Miles, T. Plunkett, 1999, Cancer treatment reviews.

Cellular immunotherapy for cancer: current concepts and clinical perspectives scientific basis and approaches for therapeutic cancer vaccines. Part I.

H. Pandha, J. Spicer, J. Spicer, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

13. NEW BIOLOGICAL THERAPIES FOR BREAST CANCER

D. Miles, T. Plunkett, D. Miles, 2002, International journal of clinical practice.

Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer

D. Miles, D. Barnes, R. Rubens, 1999, British Journal of Cancer.

Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer

H. Pandha, S. Chan, N. Somaiah, 2005, Prostate Cancer and Prostatic Diseases.

Quality trials and quality of life in non-small-cell lung cancer.

D. Khayat, P. Harper, T. Plunkett, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CEACAM1: a marker with a difference or more of the same?

P. Ellis, T. Plunkett, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of positron emission tomography in the management of colorectal cancer

A. Tutt, S. Barrington, M. Leslie, 2004, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Cellular immunotherapy for cancer: current concepts and clinical perspectives Monitoring immune responses and clinical trials: part II.

H. Pandha, J. Spicer, T. Plunkett, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy.

D. Miles, R. Rubens, A. Hanby, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.